Piramal Critical Care and Blue-Zone Technologies Partner on Anesthesia Gas Capture and Recycling

Piramal Critical Care, Inc. (PCC), a foreign subsidiary of Piramal Pharma Limited, and Blue-Zone Technologies Ltd. (Blue-Zone) have entered into an agreement to collaborate on the development of technology for the capture, collection, and recycling of anesthesia gases. According to the press release, the partnership aims to address the environmental impact of anesthesia gases, which are potent greenhouse gases. By working together, the companies hope to create a solution that can be deployed in healthcare facilities to reduce emissions and enable the reuse of these valuable gases. 'Anesthesia gases are an important part of modern medical care, but they also have a significant environmental footprint,' said Dr. Nandini Tandon, CEO of Piramal Critical Care. 'Our collaboration with Blue-Zone will allow us to develop innovative technology to capture these gases and give them a second life, supporting our commitment to sustainability and environmental stewardship.' Blue-Zone Technologies is a leader in anesthesia gas management solutions, with a track record of developing technologies to reduce waste and emissions in healthcare. 'We're excited to partner with Piramal Critical Care to expand the reach and impact of our anesthesia gas capture and recycling systems,' said James Millar, CEO of Blue-Zone. 'Together, we can make a meaningful difference in reducing the carbon footprint of the medical sector.' The announcement highlights the growing focus on environmental sustainability within the maritime industry, as companies seek to address their environmental impact and meet evolving regulatory requirements. This partnership represents an important step forward in reducing greenhouse gas emissions from the healthcare sector, which has implications for the broader maritime supply chain.